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Several studies of chronic obstructive pulmonary disease (COPD) have shown that pulmonary rehabilitation,
consisting of at least three training sessions a week, improves exercise performance and health status. This study
investigates feasibility, eect and economic aspects of a rehabilitation programme consisting of two sessions a week
for 8 weeks.
Twenty-four patients with moderate COPD were randomized to rehabilitation and 21 to placebo. Patients were
assigned to an 8-week programme of exercise plus education (Exercise group) or conventional community care
(Placebo group). The rehabilitation program was carried out in a hospital outpatient setting and consisted of 16 h
exercise and 13.5 h of education. The exercise group received physiotherapy and education twice a week. Seven
patients did not complete the programme. The characteristics of the 38 COPD-patients at baseline were the
following: (mean+SD) forced expiratory volume in 1 sec (FEV1) 11+04 l (47% of predicted), 6-min walking
distance (6MWD) 413+75 m, score of St. George’s Respiratory Questionnaire (SGRQ) 44+21. Health-status,
assessed by SGRQ and The Psychological General Well-being (PGWB) Index, did not improve. Rehabilitation
resulted in an insignificant improvement in the 6MWD [29 m (95% confidence interval:78766 m)]. We conclude
that a rehabilitation program consisting of exercise and education twice a week for 8 weeks had no eect on exercise
performance and well being in patients with moderate COPD.
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Pulmonary rehabilitation is a set of tools and disciplines
which is applied to diminish, and at best revert, the
pathophysiological mechanisms causing low physical capa-
city and reduced life quality in patients with chronic
obstructive pulmonary disease (COPD). Important ele-
ments of pulmonary rehabilitation (PR) are smoking
cessation, optimal medical treatment, focus on psychosocial
mechanisms, self-control occupational therapy, nutritional
therapy and exercise (1,2). For many years, the first two
elements have been the corner-stone in the treatment of
patients with COPD, whereas the other elements are new
areas where little investigation has been carried out.
Studies have shown that PR with exercise 3–7 times
weekly improves quality of life and exercise tolerance in
patients with moderate COPD (3–8). In a study without a
control group, exercise with high intensity resulted in a
significantly more increased exercise tolerance (9). Yet atReceived 4 August 1999 and accepted 22 September 1999
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not clarified. The aim of this controlled study was to
evaluate the eect of a rehabilitation programme consisting
of exercise twice a week with moderate intensity in
moderate COPD. In addition the study focused on aspects
of recruitment and economy in pulmonary rehabilitation.
Patients and methods
PATIENTS
For a period of 6 months, patients were recruited from the
outpatient clinic of Bispebjerg Hospital. The entry criteria
were: stable COPD with FEV1/FVC-ratio 570%, FEV1
406, age 575 years and an oxygen saturation without
oxygen supply 490%. Patients were excluded if they
participated in an exercise programme, had another serious
disease, such as cancer, had home oxygen therapy, were
senile or suered from a psychiatric disorder, or were
dependent on walking equipment. Of 130 contacted
patients 48 entered. Three of the patients were excluded
due to very low FEV1. In a randomized and controlled# 2000 HARCOURT PUBLISHERS LTD
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tion (active group), whereas the remaining 21 patients acted
as a control group. The active group was divided into a
spring and an autumn-team, each with 12 patients. The
local ethical committee approved the study and all patients
gave their informed written consent.
REHABILITATION PROGRAMME
The programme consisted of 2 weekly sessions of 2 h for 8
weeks. Patients trained together at the hospital for 1 h each
time. The exercise was conducted by a physiotherapist and
consisted of warming-up, mobility training, coordination
tests, dynamic strength exercise of upper and lower
extremities and abdominal musculature, stair climbing
and jogging as endurance training, stretching and relaxa-
tion. The intensity and load of the exercise were individua-
lized so the patients achieved a dyspnoea-score of 4–5 on a
scale to 10 (10). Patients were instructed in using pursed-lip
breathing during exercise. In the remaining hours, patients
were educated in the dierent aspects of COPD by a doctor
and a nurse. They received counselling by a nutritional
therapist and by an occupational therapist. Patients were
delivered elastic bands and a copy of the training
programme, so they could train at home. To succeed, the
patients had to participate in at least half of the
programme.
EFFECT PARAMETERS
Patients were asked to walk as far as possible for 6 min with
standardized pacing (11) along a 30 m corridor (6-min
walking test). Dyspnoea was measured before and after the
walking test on the Borg scale (10). Quality of life wasTABLE 1. Characteristics of the patients at baseline
Active (n2
Age (years) 618+68
Gender (male/female) 1/23
FEV1(% of predicted value) 495+174
Pulse saturation of oxygen (%) 953+16
Current smoking (yes/no) 16/8
CO in expired air (ppm) 13 (1–41)
Body Mass Index (kg m72) 261+56
Steroid per os (yes/no) 3/21
Steroid inhaled (yes/no) 19/5
Borg dyspnoea-score at rest 12+14
Borg dyspnea-score after walking 49+19
Change in dyspnea-score 36+17
6-MWD (m) 377+78
PGWB-index 068+015
SGRQ-total score 477+159
Mean+SD is indicated for continuous variables, except for CO
significant.assessed by means of the St. George’s Respiratory
Questionnaire (SGRQ) and by means of the Psychological
General Well-being (PGWB) index (12,13). Quality of life
scores, 6-min walking test and Borg dyspnoea-score were
evaluated before and after the 8 weeks.
STATISTICS
For each outcome, an unpaired t-test of the dierence
between baseline and follow-up in the active group vs. the
control group was done. The 95%-confidence interval
around mean dierences was calculated. SPSS version 80
(SPSS Inc., Chicago, IL, U.S.A.) was used.
Results
Of the 24 patients in the active group, seven did not
complete the programme: three due to exacerbation in
COPD, two due to myalgia, one due to lack of time and one
gave no reason. With regard to baseline characteristics,
these patients did not dier from the patients who
completed the rehabilitation. The majority of patients were
females who had a moderate degree of COPD (Table 1). In
the active group significantly more patients were females,
were current smokers and had a better 6-min walking test as
compared with the control group. In both the active and
control groups, 6-min walking distance and symptom-score
were unchanged after 8 weeks and there was no dierence
between the two groups (Table 2).
A total of 90 sta-hours were used in the study: nurses
(30), doctors (18), physiotherapist (36), nutritional therapist
(3) and occupational therapist (3). The salary amounted to
approximately 2000 US $. Eight patients required trans-
portation arranged by the hospital at approx. 1800 US $.4) Control (n21) P-value
646+77 n.s.
6/15 0039
443+137 n.s.
953+13 n.s.
7/14 0038
4 (1–42) n.s.
241+36 n.s.
3/18 n.s.
15/6 n.s.
09+10 n.s.
49+20 n.s.
40+19 n.s.
433+62 0013
072+013 n.s.
422+157 n.s.
in expired air, where median (range) is indicated. n.s.: non-
TABLE 2. Eect of rehabilitation assessed by symptoms and 6-min walking test
Active (n17) Control (n21) Dierence (95% CI)
Change in 6-MWD (m) 105+450 7185+620 290 (781–661)
Change in PGWB-index 0049+013 70012+011 006 (70021–0142)
Change in SGRQ-score 721+181 721+106 01 (798–100)
Change in dyspnea-score, rest 04+17 09+13 705 (715–06)
Change in dyspnoea-score, after walking test 707+30 711+14 05 (71.1–21)
Mean+SD. CI: Confidence interval. Two patients in the control group failed to appear at the 8-week re-test.
152 T. J. RINGBAEK ET AL.Expenses of equipment were very low. As the space
accommodation was disposed freely by the hospital, the
cost of rent was not included.
Discussion
In this study, we were not able to find a significant eect of
pulmonary rehabilitation on physical performance and well
being. As this is inconsistent with previous findings (3–8), it
is natural to consider a number of possible causes: selection
of patients, type II-error, short duration of the training
programme, low intensity, low frequency and dierent
compositions of the training programme. Finally, one could
speculate that the chosen eect parameters were too
insensitive. In the following the above mentioned items
will be discussed.
SELECTION OF PATIENTS
Our inclusion and exclusion criteria did not dier
essentially from the criteria applied in other studies of
pulmonary rehabilitation (4,6). The criteria were perhaps
less restrictive and in practice only patients with severe
COPD were excluded. Eligible patients were easily found,
but surprisingly few patients were interested. Thus, we had
to contact 130 patients in order to randomize 45. Not all of
the previous studies explained how the patients were
recruited but, in general, one has to evaluate three patients
for each randomized patient (6–8, 14). On the other hand if
the patients were referred for a purpose of rehabilitation,
and therefore highly motivated, up to 90% of the patients
could be randomized (4).
As reflected by distribution of gender among patients, we
found it dicult to motivate males to rehabilitation, but
otherwise our patients were not dierent from patients in
the studies where eect of rehabilitation was shown.
In the control group, more patients were females and
current smokers, and they had a higher 6-min walking
distance at randomization as compared with the active
group. So far, the influence of gender and smoking habits
on pulmonary rehabilitation has not been evaluated. In an
uncontrolled study, the eect of rehabilitation, assessed by
the 6-min walking distance, was inversely proportional with
the initial distance (15). Patients with severe dyspnoea
seemed to gain no or very little benefit of the pulmonaryrehabilitation (4,16). Yet in our study, in spite of quite low
FEV1 patients in both groups had very little dyspnoea and
symptoms as compared with patients, who benefited from
the rehabilitation programme in the above mentioned
studies (4,16).
In case of a type II-error an eect of rehabilitation can be
missed. Our study was dimensioned to detect a change in 6-
min walking distance and symptom-score of about 13%,
which should be sucient to be of clinical relevance (17,18).
As other studies, with fewer patients, had been able to
shown an eect, we believe that type II-error is not a
problem in our study (3,5,6,14).
EFFECT PARAMETERS
The 6-min walking test and SGRQ are both approved
outcomes. Two meta-analyses have shown that rehabilita-
tion has a significant and clinical relevant eect on health-
related quality of life and exercise tolerance (19). However,
a certain relationship between these eects has not been
shown (4). Besides improved exercise tolerance, other
factors like better self-control and increased activities of
daily living through occupational counselling and establish-
ment of social contacts are expected to improve the quality
of life. In connection with pulmonary rehabilitation few
studies have evaluated the long-term eect on the quality of
life. The results are ambiguous. In a study of 119 patients,
Ries et al. found a modest decreasing eect after 2 months,
while Bredstrup et al. found an increasing eect 12 weeks
after the end of the rehabilitation programme (6,7). Both
studies encouraged the patients to continue exercise at
home.
DURATION, FREQUENCY, INTENSITY AND
COMPOSITION OF THE TRAINING
PROGRAMME
According to the literature, 8 weeks of pulmonary
rehabilitation is sucient, and the elements and the
intensity of the exercise in our study did not dier from
other studies, where rehabilitation has benefitted the
patients (4,5,7). Among selected randomized and controlled
studies in an outpatient setting, the eect of rehabilitation,
assessed by the walking endurance, varies from 7% (in our
study) to 54% with increasing frequency of exercise (Fig. 1).
FIG. 1. The influence of the exercise frequency on the 6-
min walking distance. Each dot represents a placebo-
controlled study on pulmonary rehabilitation in an
outpatient setting with a 6-min walking distance as an
outcome. The numbers of the references are displayed. In
two studies, the 6MWD was calculated as 50% of the 12-
min walking distance (3,5). BBH: Bispebjerg Hospital
Study.
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having two exercise sessions a week. The negative results of
our study could thus be interpreted as a support for the
recommendation, that patients have to exercise at least
every second day (2).
ECONOMY
When a new treatment is introduced, considerations about
cost-eectiveness ought to be done. Very few studies report
on costs of rehabilitation programmes. As clear instruction
of how to calculate costs does not exist, one should be
cautious about making a comparison. In a previous Danish
study, 124 sta-hours were required in a programme of 12
weeks with 16 patients (6). In Denmark, the cost of salary
to the sta is estimated at 8 US $ h71 patient71. Thus, the
cost of a programme with exercise three times a week for 10
weeks would be about 3800 US $ without inclusion of the
cost of transportation and accommodation.
Conclusion
Pulmonary rehabilitation is directed to a selected group of
patients with COPD. Only a third of the contacted patients
was interested and only three quarters of the included
patients completed the programme. Patients with a
moderate degree of COPD did not benefit from a
rehabilitation programme of 8 weeks with 2 weekly
sessions. As we think that low frequency of exercise is
most probably the cause of this failure, we recommend thatexercise at least 3 times a week should be included in the
future programmes.
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